Welcome to LookChem.com Sign In|Join Free

CAS

  • or

470690-00-7

Post Buying Request

470690-00-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

470690-00-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 470690-00-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,0,6,9 and 0 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 470690-00:
(8*4)+(7*7)+(6*0)+(5*6)+(4*9)+(3*0)+(2*0)+(1*0)=147
147 % 10 = 7
So 470690-00-7 is a valid CAS Registry Number.

470690-00-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl 4-[4-(N-phenylanilino)piperidin-1-yl]piperidine-1-carboxylate

1.2 Other means of identification

Product number -
Other names TERT-BUTYL 4-(4-(DIPHENYLAMINO)PIPERIDIN-1-YL)PIPERIDINE-1-CARBOXYLATE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:470690-00-7 SDS

470690-00-7Downstream Products

470690-00-7Relevant articles and documents

Orally Bioavailable Competitive CCR5 Antagonists

Thoma, Gebhard,Nuninger, Fran?ois,Schaefer, Marc,Akyel, Kayhan G.,Albert, Rainer,Beerli, Christian,Bruns, Christian,Francotte, Eric,Luyten, Marcel,MacKenzie, Duncan,Oberer, Lukas,Streiff, Markus B.,Wagner, Trixie,Walter, Hansrudolf,Weckbecker, Gisbert,Zerwes, Hans-Guenter

, p. 1939 - 1955 (2007/10/03)

The chemokine receptor CCR5 plays an important role in inflammatory and autoimmune disorders as well as in transplant rejection by affecting the trafficking of effector T cells and monocytes to diseased tissues. Antagonists of CCR5 are believed to be of potential therapeutic value for the disorders mentioned above and HIV infection. Here we report on the structure-activity relationship of a new series of highly potent and selective competitive CCR5 antagonists. While all compounds tested were inactive on rodent CCR5, this series includes compounds that cross-react with the cynomolgus monkey (cyno) receptor. One of these compounds, i.e., 26n, has good PK properties in cynos, and its overall favorable profile makes it a promising candidate for in vivo profiling in transplantation and other disease models.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 470690-00-7